BioSpace News Archive

Mammoth will use the funds to build and broaden its stable of next-generation CRISPR products to detect and cure various diseases.

Quanterix Corporation today announced a webinar hosted by Kevin Hrusovsky, Quanterix Chairman and Chief Executive Officer, with leading pathologist Dr. John Roback, M.D., Ph.D.

Promis Diagnostics, Inc., a molecular diagnostics company focused on early cancer diagnosis, recently presented clinical validation data for CystoChek, its proprietary urine-based DNA methylation test of PENK for bladder cancer detection in hematuria, at the 2021 American Urological Association Annual Meeting.

Bristol Myers Squibb announced findings from a global real-world evidence study that the risk of mortality increases with worse New York Heart Association functional class for patients with obstructive hypertrophic cardiomyopathy.

Synlogic, Inc. today presented on the development of investigational Synthetic Biotic medicines for the treatment of Phenylketonuria (PKU) at the Global PKU Patient Meeting, being held virtually September 10-11th, 2021.

Synlogic, Inc.today announced that it will present data on SYNB8802, an investigational Synthetic Biotic medicine for the treatment of Enteric Hyperoxaluria (HOX), during the American Urological Association (AUA) Annual Meeting, being held virtually September 10 – 13th.

Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the BofA Global Healthcare Conference.

Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, Dr James Garner, will be presenting at the HC Wainwright 23rd Annual Global Investment Conference, to be held virtually from 13-15 September 2021.

The latest study by specialist recruitment firm EPM Scientific discovered 60% of professionals shared a positive sentiment regarding the current job market.

Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference